A double-blind, placebo-controlled trial on the antihypertensive treatment effect of a quadruple single-pill combination.

In a randomized, double-blind, placebo-controlled trial, we investigated antihypertensive treatment effect of a quadruple single-pill combination of reserpine 0.1 mg, dihydralazine 12.5 mg, hydrochlorothiazide 12.